However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

A new CDC report reveals that over 15.5 million U.S. adults have ADHD, with 71.5 per cent facing difficulties obtaining ...

India’s powerful copycat pharmaceutical industry is set to roll out generic weight-loss drugs in the UK within weeks, with one leading producer forecasting a “huge price war t ...

In the ever-changing healthcare landscape, it is crucial to develop sustainable long-term strategies that look beyond ...

We love hearing from you. Lilah is on Instagram @ lilahrap, and email at [email protected]. And we’re grateful for reviews on Apple and Spotify! – Jo’s column about the silence around weight loss in ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

This is an audio transcript of the Life and Art from FT Weekend podcast episode: ‘Fashion loves Ozempic. Should we talk about it?’ ...

In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company ...

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...

Tens of thousands of New Jersey police officers are feeling the squeeze of rising health insurance premiums, according to the ...

Medics have shared a cautionary tale, based on real stories of patients they have seen, of a women who fell into a trap posed ...